# Bristow Group Inc.: financial statements, quarterly

VTOL · NYSE · CIK 1525221 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vtol.md) · [Financials](/companies/vtol/financials.md) · [Filings](/companies/vtol/filings.md) · [Insiders](/companies/vtol/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vtol/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [326](/filings/0001525221-23-000060.md) | [332 d](/filings/0001525221-24-000011.md) | [337](/filings/0001525221-25-000032.md) | [360](/filings/0001525221-25-000047.md) | [365](/filings/0001525221-25-000073.md) | [354 d](/filings/0001525221-26-000013.md) | [351](/filings/0001525221-26-000082.md) | [376](/filings/0001525221-26-000100.md) | [386](/filings/0001525221-25-000073.md) | [377 d](/filings/0001525221-26-000013.md) | [389](/filings/0001525221-26-000082.md) | [412](/filings/0001525221-26-000100.md) |
| Selling, general and administrative | $m | [46.3](/filings/0001525221-24-000067.md) | [44.1 d](/filings/0001525221-24-000011.md) | [43.3](/filings/0001525221-24-000039.md) | [44.9](/filings/0001525221-24-000061.md) | [42.9](/filings/0001525221-24-000067.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | not reported | not reported | [22.8](/filings/0001525221-25-000032.md) | [44.8](/filings/0001525221-25-000047.md) | [33.2](/filings/0001525221-25-000073.md) | [31.8 d](/filings/0001525221-26-000013.md) | [33.5](/filings/0001525221-26-000082.md) | [42.6](/filings/0001525221-26-000100.md) | [50.5](/filings/0001525221-25-000073.md) | [32.1 d](/filings/0001525221-26-000013.md) | [34.7](/filings/0001525221-26-000082.md) | [39.6](/filings/0001525221-26-000100.md) |
| Interest expense | $m | [10.0](/filings/0001525221-23-000060.md) | [11.3 d](/filings/0001525221-24-000011.md) | [9.5](/filings/0001525221-24-000039.md) | [9.4](/filings/0001525221-25-000047.md) | [9.7](/filings/0001525221-25-000073.md) | [9.1 d](/filings/0001525221-26-000013.md) | [9.5](/filings/0001525221-26-000082.md) | [10.0](/filings/0001525221-26-000100.md) | [10.0](/filings/0001525221-25-000073.md) | [10.4 d](/filings/0001525221-26-000013.md) | [13.8](/filings/0001525221-26-000082.md) | [12.2](/filings/0001525221-26-000100.md) |
| Income tax | $m | [22.6](/filings/0001525221-24-000067.md) | [21.6 d](/filings/0001525221-26-000013.md) | [2.5](/filings/0001525221-25-000032.md) | [9.2](/filings/0001525221-25-000047.md) | [8.4](/filings/0001525221-25-000073.md) | [(13.0) d](/filings/0001525221-26-000013.md) | [10.2](/filings/0001525221-26-000082.md) | [20.4](/filings/0001525221-26-000100.md) | [(11.8)](/filings/0001525221-25-000073.md) | [3.0 d](/filings/0001525221-26-000013.md) | [3.5](/filings/0001525221-26-000082.md) | [0.1](/filings/0001525221-26-000100.md) |
| Net income | $m | [4.3](/filings/0001525221-24-000067.md) | [(7.9) d](/filings/0001525221-26-000013.md) | [6.6](/filings/0001525221-25-000032.md) | [28.2](/filings/0001525221-25-000047.md) | [28.2](/filings/0001525221-25-000073.md) | [31.8 d](/filings/0001525221-26-000013.md) | [27.4](/filings/0001525221-26-000082.md) | [31.7](/filings/0001525221-26-000100.md) | [51.5](/filings/0001525221-25-000073.md) | [18.4 d](/filings/0001525221-26-000013.md) | [13.1](/filings/0001525221-26-000082.md) | [21.2](/filings/0001525221-26-000100.md) |
| Diluted EPS | $ per share | [0.15](/filings/0001525221-24-000067.md) | not reported | [0.23](/filings/0001525221-25-000032.md) | [0.96](/filings/0001525221-25-000047.md) | [0.95](/filings/0001525221-25-000073.md) | not reported | [0.92](/filings/0001525221-26-000082.md) | [1.07](/filings/0001525221-26-000100.md) | [1.72](/filings/0001525221-25-000073.md) | not reported | [0.44](/filings/0001525221-26-000082.md) | [0.70](/filings/0001525221-26-000100.md) |
| Basic EPS | $ per share | [0.15](/filings/0001525221-24-000067.md) | not reported | [0.23](/filings/0001525221-25-000032.md) | [0.99](/filings/0001525221-25-000047.md) | [0.99](/filings/0001525221-25-000073.md) | not reported | [0.95](/filings/0001525221-26-000082.md) | [1.10](/filings/0001525221-26-000100.md) | [1.79](/filings/0001525221-25-000073.md) | not reported | [0.45](/filings/0001525221-26-000082.md) | [0.71](/filings/0001525221-26-000100.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [208](/filings/0001525221-23-000060.md) | [180](/filings/0001525221-25-000016.md) | [141](/filings/0001525221-24-000039.md) | [179](/filings/0001525221-24-000061.md) | [200](/filings/0001525221-24-000067.md) | [248](/filings/0001525221-26-000013.md) | [191](/filings/0001525221-25-000032.md) | [252](/filings/0001525221-25-000047.md) | [246](/filings/0001525221-25-000073.md) | [286](/filings/0001525221-26-000100.md) | [342](/filings/0001525221-26-000082.md) | [312](/filings/0001525221-26-000100.md) |
| Current assets | $m | [558](/filings/0001525221-23-000060.md) | [564](/filings/0001525221-25-000016.md) | [524](/filings/0001525221-24-000039.md) | [571](/filings/0001525221-24-000061.md) | [594](/filings/0001525221-24-000067.md) | [619](/filings/0001525221-26-000013.md) | [615](/filings/0001525221-25-000032.md) | [670](/filings/0001525221-25-000047.md) | [678](/filings/0001525221-25-000073.md) | [694](/filings/0001525221-26-000100.md) | [792](/filings/0001525221-26-000082.md) | [755](/filings/0001525221-26-000100.md) |
| Total assets | $m | [1,890](/filings/0001525221-23-000060.md) | [1,937](/filings/0001525221-25-000016.md) | [1,916](/filings/0001525221-24-000039.md) | [1,977](/filings/0001525221-24-000061.md) | [2,088](/filings/0001525221-24-000067.md) | [2,125](/filings/0001525221-26-000013.md) | [2,172](/filings/0001525221-25-000032.md) | [2,288](/filings/0001525221-25-000047.md) | [2,270](/filings/0001525221-25-000073.md) | [2,311](/filings/0001525221-26-000100.md) | [2,405](/filings/0001525221-26-000082.md) | [2,383](/filings/0001525221-26-000100.md) |
| Current liabilities | $m | [326](/filings/0001525221-23-000060.md) | [310](/filings/0001525221-25-000016.md) | [303](/filings/0001525221-24-000039.md) | [306](/filings/0001525221-24-000061.md) | [324](/filings/0001525221-24-000067.md) | [326](/filings/0001525221-26-000013.md) | [335](/filings/0001525221-25-000032.md) | [371](/filings/0001525221-25-000047.md) | [355](/filings/0001525221-25-000073.md) | [365](/filings/0001525221-26-000100.md) | [367](/filings/0001525221-26-000082.md) | [334](/filings/0001525221-26-000100.md) |
| Total liabilities | $m | [1,094](/filings/0001525221-23-000060.md) | [1,114](/filings/0001525221-25-000016.md) | [1,096](/filings/0001525221-24-000039.md) | [1,129](/filings/0001525221-24-000061.md) | [1,190](/filings/0001525221-24-000067.md) | [1,234](/filings/0001525221-26-000013.md) | [1,241](/filings/0001525221-25-000032.md) | [1,304](/filings/0001525221-25-000047.md) | [1,234](/filings/0001525221-25-000073.md) | [1,252](/filings/0001525221-26-000100.md) | [1,346](/filings/0001525221-26-000082.md) | [1,293](/filings/0001525221-26-000100.md) |
| Long-term debt | $m | [531](/filings/0001525221-23-000060.md) | [535](/filings/0001525221-25-000016.md) | [531](/filings/0001525221-24-000039.md) | [578](/filings/0001525221-24-000061.md) | [612](/filings/0001525221-24-000067.md) | [671](/filings/0001525221-26-000013.md) | [683](/filings/0001525221-25-000032.md) | [680](/filings/0001525221-25-000047.md) | [653](/filings/0001525221-25-000073.md) | [644](/filings/0001525221-26-000100.md) | [727](/filings/0001525221-26-000082.md) | [718](/filings/0001525221-26-000100.md) |
| Current portion of debt | $m | [12.7](/filings/0001525221-23-000060.md) | [13.2](/filings/0001525221-25-000016.md) | [13.1](/filings/0001525221-24-000039.md) | [15.9](/filings/0001525221-24-000061.md) | [16.9](/filings/0001525221-24-000067.md) | [18.6](/filings/0001525221-26-000013.md) | [19.2](/filings/0001525221-25-000032.md) | [24.8](/filings/0001525221-25-000047.md) | [22.1](/filings/0001525221-25-000073.md) | [27.9](/filings/0001525221-26-000100.md) | [27.4](/filings/0001525221-26-000082.md) | [27.4](/filings/0001525221-26-000100.md) |
| Shareholders' equity | $m | [796](/filings/0001525221-23-000060.md) | [824](/filings/0001525221-25-000016.md) | [821](/filings/0001525221-24-000039.md) | [849](/filings/0001525221-24-000061.md) | [899](/filings/0001525221-24-000067.md) | [892](/filings/0001525221-26-000013.md) | [932](/filings/0001525221-25-000032.md) | [984](/filings/0001525221-25-000047.md) | [1,036](/filings/0001525221-25-000073.md) | [1,060](/filings/0001525221-26-000100.md) | [1,059](/filings/0001525221-26-000082.md) | [1,089](/filings/0001525221-26-000100.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [16.7 d](/filings/0001525221-24-000067.md) | [(9.5) d](/filings/0001525221-26-000013.md) | [26.7](/filings/0001525221-25-000032.md) | [33.7 d](/filings/0001525221-25-000047.md) | [66.0 d](/filings/0001525221-25-000073.md) | [51.1 d](/filings/0001525221-26-000013.md) | [(0.6)](/filings/0001525221-26-000082.md) | [99.0 d](/filings/0001525221-26-000100.md) | [23.1 d](/filings/0001525221-25-000073.md) | [76.9 d](/filings/0001525221-26-000013.md) | [(8.3)](/filings/0001525221-26-000082.md) | [41.1 d](/filings/0001525221-26-000100.md) |
| Capital expenditure | $m | [18.4 d](/filings/0001525221-24-000067.md) | [19.4 d](/filings/0001525221-26-000013.md) | [64.6](/filings/0001525221-25-000032.md) | [50.4 d](/filings/0001525221-25-000047.md) | [57.0 d](/filings/0001525221-25-000073.md) | [83.5 d](/filings/0001525221-26-000013.md) | [52.1](/filings/0001525221-26-000082.md) | [31.6 d](/filings/0001525221-26-000100.md) | [29.2 d](/filings/0001525221-25-000073.md) | [29.1 d](/filings/0001525221-26-000013.md) | [41.3](/filings/0001525221-26-000082.md) | [67.4 d](/filings/0001525221-26-000100.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001525221-26-000082.md) | [0.0 d](/filings/0001525221-26-000100.md) | not reported | not reported | [3.7](/filings/0001525221-26-000082.md) | [3.7 d](/filings/0001525221-26-000100.md) |
| Share repurchases | $m | [0.4 d](/filings/0001525221-24-000067.md) | [0.0 d](/filings/0001525221-26-000013.md) | [1.0](/filings/0001525221-25-000032.md) | [2.9 d](/filings/0001525221-25-000047.md) | [0.1 d](/filings/0001525221-25-000073.md) | [0.0 d](/filings/0001525221-26-000013.md) | [2.5](/filings/0001525221-26-000082.md) | [6.0 d](/filings/0001525221-26-000100.md) | [0.6 d](/filings/0001525221-25-000073.md) | [6.1 d](/filings/0001525221-26-000013.md) | [11.0](/filings/0001525221-26-000082.md) | [0.0 d](/filings/0001525221-26-000100.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [28.4](/filings/0001525221-23-000060.md) | [28.0](/filings/0001525221-24-000039.md) | [28.1](/filings/0001525221-24-000061.md) | [29.0](/filings/0001525221-24-000067.md) | [29.2](/filings/0001525221-25-000032.md) | [29.5](/filings/0001525221-25-000047.md) | [29.7](/filings/0001525221-25-000073.md) | [29.9](/filings/0001525221-26-000082.md) | [29.8](/filings/0001525221-26-000100.md) | [29.9](/filings/0001525221-25-000073.md) | [30.1](/filings/0001525221-26-000082.md) | [30.0](/filings/0001525221-26-000100.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 29,642,000 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001525221-26-000100.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.